The market for myopia and presbyopia treatment is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America

The market in North America held the leading share in global market in 2019 and is anticipated to continue this trend and hold the largest share of 36.12% in the market in 2028. This can be primarily attributed to the growing demand for advanced eye care products across the world. 

Moreover, the increase in investments towards healthcare by government and private entities in order to maintain the highest quality of care offered at healthcare facilities is another major growth driving factor in the region. The market in the United States is anticipated to observe the highest growth in the region, attaining a market value of USD 5,522.15 million in 2019. The market is estimated to rise on the back of increasing adoption of advanced ophthalmic diagnostic products resulting in timely identification of myopia & presbyopia, which is resulting in the high demand for effective treatment solutions. 

Europe

The market in Europe is anticipated to reach a significantly high market size of USD 9,716.29 million by 2028. It has been observed that with the rising availability of innovative treatment methods, particularly LASIK treatment, there has been a rise in demand for effective treatment products in the region. Myopia and presbyopia treatment market is primarily driven by the demand from Germany, UK, France and Italy. On account of these factors, the market in this region is expected to showcase a high growth over the forecast period.

Asia Pacific

Myopia and presbyopia treatment market in Asia Pacific is projected to grow at the highest rate during the forecast period with a CAGR of 8.87% between 2021 and 2028. The market in China is leading in this region as a result of rising availability of advanced healthcare in this region along with rising number of manufacturers investing in the country, along with others such as Japan and India to address the growing demand for advanced vision care products in this region.

Latin America

The demand for myopia & presbyopia treatment products in the Latin America region is expected to develop gradually over the forecast period. Although various public as well as private initiatives such as free eye care camps are resulting in timely diagnostics of various ophthalmic disorders, the region is presently capturing a limited market share in the global market. The market is primarily led by the high demand in Brazil where the changing consumer behavior towards preventive health measures is anticipated to result in relatively higher adoption of various treatments of the eye.

Middle East & Africa

The Middle East & Africa region is generating a moderate demand for the myopia & presbyopia treatment products. The market in this region is witnessing limited players with narrow market penetration along with low awareness regarding the innovative healthcare practices as opposed to conventional mode of care, which is resulting in a relatively modest demand from this region. However, with gradually rising disposable income, encouraging government regulatory policies, and a potential interest of global manufacturers to have a direct market presence in this region, it is predicted that the market for myopia & presbyopia treatment in the region would grow over the forecast period.

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).